Hydrocephalus Management and Shunt Complications

Hydrocephalus is a neurological disorder characterised by excessive accumulation of cerebrospinal fluid (CSF) within the cerebral ventricles, often resulting in raised intracranial pressure, ventricular dilation and potential damage to neural tissue. Management strategies aim to restore CSF circulation and pressure homeostasis through diversion or endoscopic techniques. The mainstay of treatment remains the implantation of a ventriculoperitoneal shunt system, which diverts excess fluid from the cerebral ventricles into the peritoneal cavity. Despite advances in materials and valve design, shunt systems present a substantial burden of complications, including mechanical obstruction, infection, over- or under-drainage and device migration. These failures necessitate frequent revisions, impose significant healthcare costs and contribute to long-term morbidity. Alternative approaches, such as endoscopic third ventriculostomy, offer a shunt-free solution for selected patients but carry their own risk profile and are not universally applicable. Recent research has focused on improving valve fidelity, reducing infection rates through antimicrobial materials, and developing non-invasive monitoring technologies to detect early shunt malfunction. A comprehensive understanding of the pathophysiology of CSF dynamics, immune responses in catheter infections and novel implant designs is essential to mitigate failure rates and improve patient outcomes worldwide.

Research from Nature Portfolio

No recent Nature Portfolio content available.

Hydrocephalus Management and Shunt Complications publication trend

The graph below shows the total number of articles in hydrocephalus management and shunt complications across all publications each year (not limited to Nature Index journals).

Technical terms

Cerebrospinal fluid (CSF): Clear fluid surrounding the brain and spinal cord, providing mechanical protection and nutrient transport.

Ventriculoperitoneal shunt: Implantable system that drains CSF from the cerebral ventricles to the peritoneal cavity to relieve intracranial pressure.

Endoscopic third ventriculostomy (ETV): Minimally invasive procedure creating an opening in the floor of the third ventricle to restore CSF circulation without implanted hardware.

Intracranial pressure (ICP): Hydrostatic pressure within the skull; elevated levels can cause headache, vomiting and potential neural injury.

Cracking pressure: Minimum differential pressure required to open a one-way valve and allow CSF drainage.

Complement system: Network of plasma proteins that mediate immune defence and inflammation, implicated in catheter-associated infections.

Benchtop testing: Laboratory experiments conducted under controlled conditions to characterise device performance before in vivo trials.

References

1. Fabrication and in vivo testing of a sub-mm duckbill valve for hydrocephalus treatment. Microsystems & Nanoengineering (2024).
2. C1q is elevated during chronic Staphylococcus epidermidis central nervous system catheter infection. Frontiers in Immunology (2024).
3. Continuous, noninvasive wireless monitoring of flow of cerebrospinal fluid through shunts in patients with hydrocephalus. npj Digital Medicine (2020).